ElevateBio

ElevateBio is a biotechnology company based in Cambridge, Massachusetts, founded in 2017. The company focuses on advancing cell and gene therapies (CGTs) by integrating manufacturing, technology platforms, and therapeutic development. Its mission is to make these therapies accessible and affordable for patients worldwide. ElevateBio operates a state-of-the-art facility called BaseCamp®, which provides research and development, process development, and manufacturing capabilities for CGTs. This cGMP-compliant facility supports both ElevateBio's portfolio companies and strategic partners, enabling the production of complex therapies to meet clinical and commercial needs. The company also offers various technology platforms, including gene editing and cell engineering technologies, to enhance the development of genetic medicines. Additionally, ElevateBio utilizes data and artificial intelligence to optimize therapeutic development processes. Through its innovative ecosystem, ElevateBio collaborates with portfolio companies, strategic partners, and academic researchers to advance the field of biotechnology and democratize access to advanced genetic therapies.

Research Waltham, United States ~402 employees Private · Series D

Work at ElevateBio in HR or recruiting? Claim this page

Employees
402
+2% in the 3 months to Sep 2026
Revenue / employee
$299K
Revenue ~$120M
Total funding
$1.2B
Last round Series D, May 2023
12-month attrition
16.9%
Tech: 15.7%
H1B sponsor
NA
Open jobs
6
Last 30 days

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.